Moderate COVID-19 increasses risk of blood cloots; high-dose blood thinner can prevent clots--study

Risk of dangerous blood clots linked to moderate COVID-19; high-dose blood thinner can prevent clots The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Nancy Lapid Reuters

Oct 11 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

Dangerous blood clots can occur in moderate COVID-19

A European study has found an elevated risk of a life-threatening blood clot called venous thromboembolism (VTE) in COVID-19 patients who were not critically ill. The blood clot risk had previously been associated with severe COVID-19. The researchers tracked 2,292 patients who came to hospital emergency rooms with mild or moderate COVID-19 but without VTE. Four weeks later, VTE had developed in roughly 1 of every 200 mildly ill patients who had not been hospitalized and nearly 5 of every 200 moderately ill patients overall, the researchers reported on Friday in Thrombosis Research. They conclude that doctors caring for mildly and moderately ill COVID-19 patients need to be aware of these risks, "especially in patients with moderate COVID-19 requiring hospitalization."

High-dose blood thinners prevent clots in moderate COVID-19

 ....After accounting for patients' various risk factors, that was a 32% reduction in risk with high-dose heparin, the researchers said on Monday in a report published in JAMA Internal Medicine. ...